Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-08-07Clinical Trial Update: Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 clinical trial update evaluating induction chemotherapy in young patients with locoregionally advanced nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2019-08-07Clinical Trial Update: Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial evaluating induction-concurrent chemoradiotherapy and/or accelerated fractionation in nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2019-07-22Clinical Trial Update: Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC) [Phase 2]
Phase 2 trial evaluating two loading regimens of Sunitinib or Bevacizumab alternating with cisplatin and gemcitabine as induction therapy fo…
-
CLINICAL_TRIALS trial_result · 2019-07-11Clinical Trial Update: Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With LA-NPC [Phase 2]
Phase 2 trial evaluating induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2019-07-08Clinical Trial Update: Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 Stage [Phase 3]
A Phase 3 clinical trial evaluating maintenance chemotherapy in high-metastatic risk nasopharyngeal carcinoma (N3 stage).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-06-24Clinical Trial Update: Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial evaluating autologous stem cell transplantation in patients with recurrent nasopharyngeal carcinoma; study terminated with res…
-
CLINICAL_TRIALS trial_result · 2019-06-12Clinical Trial Update: Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial investigating single-agent capecitabine as adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2019-04-30Clinical Trial Update: Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial evaluating Endostar with induction chemotherapy followed by concurrent chemoradiotherapy for locoregional nasopharyng…
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPC [Phase 3]
Phase 3 trial comparing nimotuzumab versus cisplatin with radiotherapy for locoregionally advanced nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer [Phase 2]
Phase 2 trial of BGJ398 (infigratinib) for FGFR-positive recurrent head and neck cancer was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-01Clinical Trial Update: Phase III: Assess Conventional RT w/ Conventional Plus Accelerated Boost RT in the Treatment of Nasopharyngeal CA [Phase 3]
A Phase III trial comparing conventional radiotherapy alone to conventional radiotherapy with accelerated boost radiotherapy for nasopharyng…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Delineation of Reducing Clinical Target Volume for Early-stage Nasopharyngeal Carcinoma Patients [Phase 2]
Phase 2 clinical trial update on reducing the clinical target volume for early-stage nasopharyngeal carcinoma using intensity-modulated radi…
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Target Volume Delineation After NACT in LA-NPCarcinoma Patients Treated With NACT+ CCRT [Phase 2]
A phase 2 trial completed, evaluating target volume delineation after neoadjuvant chemotherapy in locally advanced nasopharyngeal carcinoma …
-
CLINICAL_TRIALS trial_result · 2019-02-11Clinical Trial Update: Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 trial evaluating the chemotherapy combination of ifosfamide and doxorubicin in patients with refractory nasopharyngeal carcinoma w…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma [Phase 3]
This Clinical Trial Update reports an ongoing Phase 3 study evaluating gemcitabine and cisplatin with or without anlotinib in advanced nasop…
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC) [Phase 2]
A Phase 2 clinical trial evaluating Famitinib for recurrent and/or metastatic nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: 3DV+TPS Software Outlines the Radiotherapy of Nasopharyngeal Carcinoma
The clinical trial update reports the completion of a study evaluating the 3DV+TPS radiotherapy planning software for nasopharyngeal carcino…
-
CLINICAL_TRIALS trial_result · 2018-11-26Clinical Trial Update: Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial assessing bevacizumab for radiation-induced brain necrosis in patients with nasopharyngeal carcinoma has completed recruitment…
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: By Comparing TPF Induction Chemotherapy Combined With Nimotuzumab Concurrent Radiotherapy and Cisplatin Concurrent Radio-chemotherapy for Locally Advanced NPC [Phase 2]
Phase 2 clinical trial evaluating TPF induction chemotherapy with Nimotuzumab concurrent radiotherapy and cisplatin-based concurrent chemora…
-
CLINICAL_TRIALS trial_result · 2018-10-10Clinical Trial Update: Demethylated Drug in the Treatment of Nasopharyngeal Carcinoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a demethylated drug for nasopharyngeal carcinoma; current status is unknown in the provided source.
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma [Phase 1, Phase 2]
A Phase 1/2 trial assessing anlotinib in combination with gemcitabine and cisplatin for recurrent or metastatic nasopharyngeal carcinoma is …
-
CLINICAL_TRIALS trial_result · 2018-09-11Clinical Trial Update: Nimotuzumab for Recurrent Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial update for nimotuzumab in recurrent nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2018-08-02Clinical Trial Update: Adjuvant Treatment of Apatinib in Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial update on adjuvant treatment with apatinib for nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: TOMO Versus IMRT in Nasopharyngeal Carcinoma Patients
A clinical trial update comparing tomotherapy (TOMO) to standard IMRT in nasopharyngeal carcinoma. No results or status details are provided…
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma [Phase 1]
Phase Ib trial evaluating the MVA-EBNA1/LMP2 vaccine for nasopharyngeal carcinoma has been completed.